Uni-Bio Science Group Limited
UNBSF
$0.0036
$0.00360.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 17.04% | 35.67% | 56.60% | 67.03% | 84.07% |
| Total Depreciation and Amortization | 5.78% | 29.07% | 60.39% | 23.15% | -3.77% |
| Total Amortization of Deferred Charges | 815.30% | 395.48% | -4.26% | -4.26% | -4.26% |
| Total Other Non-Cash Items | 691.57% | 56.64% | -214.21% | -139.06% | -47.10% |
| Change in Net Operating Assets | -691.40% | -1,901.19% | 180.50% | 180.50% | 180.50% |
| Cash from Operations | -32.41% | 12.62% | 76.79% | 87.76% | 103.35% |
| Capital Expenditure | 36.13% | -11.07% | -110.55% | -110.55% | -110.55% |
| Sale of Property, Plant, and Equipment | -- | 34.85% | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -698.42% | -415.61% | -113.06% | -250.05% | -1,367.88% |
| Cash from Investing | -121.59% | -117.93% | -111.93% | -138.78% | -182.06% |
| Total Debt Issued | 53.88% | 93.74% | 222.15% | 222.15% | 222.15% |
| Total Debt Repaid | -16.64% | -79.70% | -386.45% | -386.45% | -386.45% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -380.61% | -480.61% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -51.85% | 381.22% | 427.71% | 243.35% | 91.14% |
| Cash from Financing | 13.41% | 169.20% | 1,098.29% | 1,004.05% | 854.57% |
| Foreign Exchange rate Adjustments | 158.52% | 62.79% | -33.42% | -46.66% | -68.59% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -308.21% | -114.04% | 319.03% | 213.33% | 112.86% |